Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency
Clinical trial NCT07385846 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07385846
- Sponsor
- Jennifer Leddon
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.